Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday. reut.rs/3NqENeO

#Pfizer Launches ‘An Accord for a Healthier World’ to Improve #Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries #equitable #access #Pfizeproud #StrongerTogether

#HealthSummitEU2022 "We know that COVID-19 will not be the last pandemic threat we face, and we must act with the same urgency in preventing and preparing for the next pandemic as we have in fighting this one. " - Ben Osborn, Regional President Pfizer Inc. hospitals

#HealthSummitEU2022 "HERA is a white page: we know what we want to do, but not how we want to achieve it. Everyone involved now will participate in the success or failure of HERA. And I'm optimistic about that." - Pierre Delsaux Director General, HERA, EU One Health

Today, I updated @Pfizer colleagues on our pledge to donate the equivalent of all profits from our sales in Russia to causes providing humanitarian support to the people of Ukraine. Proud to say we’re making good on this promise. View the message here: on.pfizer.com/39EDjQ1

To help eliminate the leading infectious cause of blindness, today at the #KigaliSummit we extended our global trachoma antibiotic donation program with Fight Trachoma through 2030. Learn more about what this means for #GlobalHealth: bit.ly/3NdVARC #BeatNTDs

At our recent European Policy Centre conference on 30 years of EU health competences @Campus_Brussels, we discussed the impact of health crises on health policy in the past three decades. Read here our takeaways, written by my team member Danielle Brady: epc.eu/en/Publication…

🇺🇸 Pfizer Inc. is one of the new investors in 🇧🇪 Ghent-based #biotech AgomAb Therapeutics, which is developing innovative treatments to repair tissue and organs damaged by #fibrosis. bit.ly/3P91WUb via De Tijd #Yes2Belgium #BeHealth

Today, the biopharmaceutical industry shares its proposal for a joint solution on more equitable access to vaccines, treatments & diagnostics in future pandemics. We call on G7, G20 United States & others to support our vision for better preparedness: ifpma.info/3yIa8ng

With the Berlin Declaration, we presented our vision for equitable access in pandemics. But "industry cannot do it alone." We call on stakeholders to play their part in shaping a future where everyone is better protected from the threat of pandemics.⬇️ bit.ly/3cGMyA8

This week a shipment of @Pfizer patented medicines & vaccines to treat & prevent life-threatening infectious diseases, inflammatory disease & certain cancers arrived in #Rwanda under An Accord for a Healthier World. We are working together to close the #healthequity gap!

Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seeks to address worldwide disparities in COVID response. reut.rs/3UsuUSb

Today we announced a Phase 1 study with BioNTech SE of an #mRNA-based combination vaccine candidate for #influenza and #COVID19, aiming to help protect against both diseases at once. Learn more: on.pfizer.com/3ThbQEN

Roche Holding has teamed up with Pfizer on a U.S. campaign to boost awareness of COVID-19 testing and treatment, the Swiss drugmaker said on Wednesday. reut.rs/3Pomedn

Pfizer said on Tuesday a combination treatment using its drug, Adcetris, met the main goal of a late-stage study of extending survival in patients with a type of blood cancer. reut.rs/43elcaM reut.rs/43elcaM

Europe's #regulatory system can be a brake or an accelerator in bringing new treatments to patients. As #science evolves, it is vital that policymakers design rules with the flexibility that the future will demand. Read more: bit.ly/4c8JtTD #WeWontRest #DIAEurope2024

Europe is the slowest region to approve new medicines. With the revision of the #EUPharmaLegislation, policymakers have an opportunity to ensure Europeans benefit from the latest advances in care, without compromising on quality and safety: bit.ly/48PLPnB #WeWontRest

2023 was a year of challenges and achievements. Our #AnnualReview spotlights the work we did this past year to improve global health and the people behind those efforts. Our CEO Albert Bourla shares more. 👇

We shared @Pfizer’s 2024 Q1 results today. We had a solid start to the year, and I’m proud that in the first three months, we reached more than 119M patients* with our medicines and vaccines. Additionally, we have made notable progress on our five strategic priorities, from

Incendie en cours à Bruxelles : les riverains invités à garder portes et fenêtres fermées (photos) lesoir.be/692765/article…